Neurobiology of Bulimia Nervosa

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

April 4, 2022

Study Completion Date

April 4, 2022

Conditions
Bulimia Nervosa
Interventions
DRUG

Estradiol

During estradiol administration, 2mg of estradiol is given twice daily via oral capsule.

DRUG

Micronized progesterone

During progesterone administration, 200mg of progesterone is given twice daily via oral capsule.

DRUG

Leuprolide Acetate

Initial 3.75 mg intramuscular injection administered approximately Day 6 of menstrual cycle and then monthly thereafter for a total of 3 months.

DRUG

Placebo Oral Capsule

Placebo is administered during the addback phase when participants are not taking active medication. Placebo is given so that medication administration occurs throughout the entire 8-week addback period in order to blind participants to when and for how long they are on the active medication.

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT04225221 - Neurobiology of Bulimia Nervosa | Biotech Hunter | Biotech Hunter